(11) Allotments for health, accident, or hospitalization insurance or other contracts which, as a secondary or incidental feature, include insurance on the life of the allotter, are not authorized.

(iii) Requests to initiate commercial life insurance allotments shall be processed only after compliance with requirements of DoD Directive 1344.1 (Part 276 of this chapter).

(3) Repayment of loans to Navy Relief Society, Army Emergency Relief, Air Force Aid Society, and American Red Cross.

(4) Allotments for support of dependents, or to provide financial assistance to relatives who are not legally designated as dependents. The payment of such an allotment to a banking institution or association shall not deprive a member of the use of the allotment authorized by subparagraph (6) of this paragraph.

(5) Voluntary liquidation of indebtedness to the United States. This includes (1), indebtedness incurred by reason of defaulted notes guaranteed by the Federal Housing Administration or the Veterans Administration; payment of amounts due under the Retired Serviceman's Family Protection Plan in the case of retired members serving on active duty; (ii) payment of delinquent Federal income taxes; and (iii) any other indebtedness to any department or agency of the U.S. Government. This authority does not include the liquidation of indebtedness to "nonappropriated fund" activities such as clubs and messes.

(6) Payment to a banking institution or association for credit to an account of the allotter. Moneys thus credited to the allotter's account may then be used for any purpose in accordance with the desires and direction of the allotter. Only one such allotment under this subparagraph shall be allowed for any service member.

(7) Repayment of loans obtained for the purchase of a home, including a mobile home or house trailer used as a residence by the allotter. This does not authorize repayment of loans for business purposes or for additions or improvements to homes, mobile homes or trailers. Allotments authorized under this subparagraph are in addition to those authorized under subparagraph (6) of this paragraph. Only one allotment

under this subparagraph shall be allowed for any service member.

(8) Charitable contributions to a Combined Federal Campaign, in accordance with DoD Directive 5035.11 and DoD Instruction 5035.5.1

(9) Deposits to the account of a member participating in the Uniformed Services Savings Deposits Program (10 U.S.C. 1035).

(b) Retired military personnel. (1) Voluntary allotments by individuals receiving retired or retirement pay shall be limited to the following:

(1) Purchase of U.S. Savings Bonds or a combination of U.S. Savings Bonds and Notes.

(ii) Payment of premiums for insurance on the life of the allotter subject to limitations prescribed in paragraph (a)(2) (i) and (ii) of this section.

(iii) Voluntary liquidation of indebtedness to the United States subject to limitations prescribed in paragraph (a) (5) of this section.

(iv) In addition to allotments authorized in paragraph (a) of this section and to assist personnel in the transition from active duty to retired status, any other allotments in effect at the time of retirement may be continued. However, if any such allotments are discontinued by order of the retiree, they may not be reestablished and no new allotments, except as authorized in subdivisions (i), (ii), and (iii) of this subparagraph may be established. Any change in the amount of such an allotment or change in the name of an allottee constitutes a discontinuance of an allotment.

(2) The retired pay allotment program may be implemented on a timephased basis, should additional personnel and other resources be required to carry out this portion of the program.

(c) Previously registered allotments. All existing approved registered allotments of military pay and allowances of individuals in active military service, and allotments from retired pay may be continued as approved allotments.

tax purposes, (2) to liquidate an indebtedness determined under applicable provisions of law to be chargeable against the serviceman's pay account, or, (3) to pay required premiums on Servicemen's Group Life Insurance.

(b) The total amount which may be allotted shall be further restricted as provided in the DoD Military Pay and Allowance Entitlements Manual,'

§ 59.4 Control and use of forms.

(a) The use by a non-Federal agency of allotments authorization forms (other than those prescribed in DoD Directive 5035.1 and DoD Instruction 5035.51 is prohibited. Local supplies of DoD component authorization forms shall be issued to personnel and disbursing officers only.

(b) Allotment authorizations of active duty enlisted personnel shall be completed and signed in the presence of a personnel or disbursing officer or one of their representatives.

This part establishes requirements for a systematic drug abuse testing program of military personnel on extended duty; to provide for early identification of individuals who require treatment and rehabilitation; to develop improved data on prevalence rates of drug abuse by area; and to provide a degree of deterrence for certain individuals.

§ 60.2 Applicability.

The provisions of this part apply to the Departments of Army, Navy, and Air Force.

§ 60.3 Policy and responsibilities.

(a) General. All members of the United States Army, Navy, Marine Corps,

1 See footnote 1 to § 59.2.

'Available at Government Printing Office.

and Air Force on extended active duty will be screened annually using a method of random testing. Biochemical testing of urine samples is the acceptable screening method, with tests sufficiently sensitive to identify to a high degree of certainty those individuals who, at the time of testing, are excreting the drugs in question. Since biochemical tests cannot differentiate drug abusers from legitimate users, medical evaluation is essential to arrive at a diagnosis. Thus, for those individuals who may be identified as positive through the biochemical screen, medical evaluation provides the only means of differentiating drug dependent individuals, casual drug abusers, legitimate drug users, and false positives.

(b) Characteristics and establishment of the random testing program. (1) The overall objectives of the random testing program are to provide a deterrent effect on experimental and casual users, and enable earlier detection of drug abusers thereby enhancing their recovery from the drug abuse syndrome prior to serious physical or psychological deterioration.

(2) The detection rate is calculable in advance as a function of the number of days per year an individual uses drugs and the proration of tests performed on each man per year. This program will generate data which may also be used to identify drug abuse trends, and geographic risk areas. Also the frequency of testing may be increased to better the odds of detecting an individual during his most vulnerable periods of service.

(3) The concept of the random testing program establishes a procedure to attain the maximum realistic detection capability within certain prescribed criteria. Although the guidance contained in Optimized Method of Random Testing. DASD(DAA) No. 1-723 is of a detailed nature, its provision is for information and assistance only. The services are authoried to develop their own random testing program utilizing the following criteria:

(i) Ensure a relatively constant workload on the urine testing labs.

(ii) Provide a completely random system of selecting those to be tested so that an individual's chances for testing will remain relatively constant throughout the year.

Filed as part of original. Extra copies available from each military service.

(iii) Be completely unannounced to the individuals tested.

(iv) Be invulnerable to prediction by the subjects based upon historical analysis.

(v) Be capable of adjusting to changing requirements.

(vi) Use the testing frequencies prescribed in § 60.5 for guidance.

(c) Laboratory methodology. The military departments will develop standardized laboratory procedures for detection of users of drugs of abuse consistent with the following:

(1) Determine the specific gravity on each sample. Individuals whose samples are found to be less than 1.010 specific gravity will be required to submit another specimen for testing.

(2) Collect urine specimens for testing under direct observation, minimum volume 50 milliliters, properly label for positive identification and forward to the laboratory under secure conditions without preservation or refrigeration to arrive within 5 days of specimen collection.

(3) For drug screening, apply a single set of drug detection sensitivity levels, regardless of the screening method used, as follows:

(i) Total Morphine-0.5 microgram/ milliliter

(ii) Methadone/Codeine-1.0 gram/milliliter

micro

(iii) Amphetamines--5.0 microgram/ milliliter

(iv) Barbiturates 1.0

milliliter

microgram/

(4) For laboratory confirmation use gas liquid chromatography.

(5) The laboratory will report electrically, within 48 hours of receipt of the specimen, confirmed positive results to the originating agency for medical evaluation. A written follow-up report of results will be provided on all specimens received.

(d) Quality control. Pursuant to authority in 37 F.R. 3772, Secretary of the Army is designated the Executive Agent for coordinating quality control of the drug detection program of the military departments. The objective is to establish a single quality control program applicable to all in-service laboratories of the military departments and to civilian contract laboratories, with the quality control activity performed by the Armed Forces Institute of Pathology. Each of the services will support as necessary the Army's function as quality control agent for the triservice urine

testing program. The provisions of the Armed Services Procurement Regulations 32 CFR 1-30 will be observed in contractual arrangements with civilian agencies.

(e) Geographic area testing responsibilities.' The assigned geographic areas of responsibility for drug testing are shown in Section II of § 60.5(b) below. Since they vary in their drug prevalence and military populations, a redistribution of testing assignments may be made in the future. The designated drug risk areas and frequency of testing shown in the Testing Criteria (§ 60.5 (a)) were determined in accordance with drug abuse experience or predicted drug availability.

(f) Service personnel to be tested. (1) All members of the Army, Navy, Marine Corps, and Air Force on extended active duty will be tested in accordance with random methods to at least the minimum frequencies prescribed herein. In addition, certain mandatory event testing is required:

(i) Initial entry into active duty.

(ii) DEROS (Vietnam and Thailand). (iii) First reenlistments.

(2) The following types of military personnel are classified as high risk, for testing purposes, and shall be tested at a more frequent rate:

(i) Drug rehabilitants undergoing treatment at rehabilitation centers.

(ii) Staff members supporting rehabilitation efforts.

(iii) Rehabilitatees on return to duty. (3) Schedules of testing for the foregoing are included in testing criteria (§ 60.5(a)).

§ 60.4 Periodic review.

Review of the testing program will be conducted on a semiannual basis with notice provided by ASD(H&E) on his designee. For planning purposes the first review will be a triservice conference scheduled for July 1972.

§ 60.5 Testing criteria and geographic areas of responsibility."

(a) Testing criteria-(1) Random testing frequency. (i) High Risk AreasAverage 3.0 Tests Per Person/Year:

(a) Vietnam (b) Thailand (c) Philippines (d) Okinawa;

(ii) Moderate Risk Areas-Average 1.6 Tests Per Person/Year:

*Illustrative map-filed as part of original.

(a) Korea

(b) West Coast CONUS'

(c) Northeast Coast CONUS'

(d) Taiwan;

(iii) Minimum Risk Areas-Average 1.2 Tests Per Person/Year. All other geographical areas not listed above.

(2) Mandatory event testing. (1) Initial entry into Service and first reenlistment.

(ii) DEROS-Vietnam and Thailand. (iii) Drug rehabilitation patients-a minimum of two tests per week.

(iv) Drug rehabilitation staff-one test per week, date selected randomly.

(v) Rehabilitatees on return to dutytwice a month for the first year after return to duty.

(vi) Commanders are allowed the flexibility of implementing tests peculiar to local areas or for local determined needs providing the military service responsible for the geographic area testing agrees that laboratories supporting such tests are capable of handling the extra load. (b) Geographical areas of responsibility.

The following definitions are intended for administrative use and are not necessarily applicable to the administration of military justice under the Uniform Code of Military Justice.

(a) Narcotics. Any opiates or cocaine. (b) Marijuana. The intoxicating products of the hemp plant, cannabis sativa. (c) LSD. Lysergic acid diethylamide, a dangerous drug.

(d) Dangerous drugs. Those nonnarcotic drugs that are habit-forming or have a potential for abuse because of their stimulant, depressant, or hallucinogenic effect, as determined by the Attorney General of the United States. (See Title 21 of the Code of Federal Regulations.)

(e) Drugs. As used in general terms in this directive means any of the narcotics, marijuana, or other dangerous drugs defined in paragraphs (a), (b), (c), and (d), of this section.

(f) Drug abuse. The illegal, wrongful or improper use of any narcotic substance, marijuana, or dangerous drug, or the illegal or wrongful possession, transfer, or sale of the same. When such drugs have been prescribed by competent medical personnel for medical purposes their proper use by the patient prescribed for is not drug abuse.

(g) Drug abuser. One who has 11legally, wrongfully, or improperly used any narcotic substance, marijuana, or dangerous drug, or who has illegally or wrongfully possessed, transferred, or sold the same:

(1) Drug experimenter. One who has illegally, wrongfully, or improperly used any narcotic substance, marijuana or dangerous drug as defined herein not more than a few times for reasons of curiosity, peer pressure, or other similar reason. The exact number of usages is not necessarily as important in determining the category of user as is the intent of the user, the circumstances of use, and the psychological makeup of the user. Final determination of the category should be within the judgment of

the Commanding Officer, aided by medical, legal, and moral advice.

(2) Drug user. One who has illegally, wrongfully, or improperly used any narcotic substance, marijuana, or dangerous drug as defined herein generally several times, and for reasons of a deeper and more continuing nature than those which motivate the drug experimenter. Final determination of the category should be within the judgment of the Commanding Officer aided by medical, legal, and moral advice.

(3) Drug addict. One who exhibits a behavioral pattern of compulsive drug use, characterized by overwhelming involvement with the use of a drug, and the securing of its supply. As the term "drug addict" is used herein, one may or may not be physically dependent on the drug. Rather, the term refers in a quantitative sense to the degree to which drug use pervades the total life activity of the user.

(h) Supplier. One who furnished 11legally, wrongfully, or improperly any of the proscribed drugs defined herein to another person.

(1) Casual supplier. One who furnished illegally, wrongfully, or improperly to another person a small amount of any of the proscribed drugs defined herein for the convenience of the user rather than for gain.

§ 62.4 Policies and responsibilities.

It is the policy of the Department of Defense to prevent and eliminate drug abuse within the armed forces and to attempt to restore members so involved to useful service. The illegal or improper use of drugs by a member of the armed forces may have a seriously damaging effect on his health and mind, may jeopardize his safety and the safety of his fellows, may lead to criminal prosecution and to discharge under other than honorable conditions and is altogether incompatible with military service or subsequent civilian pursuits. Further, these policies shall extend, as appropriate, to the civilian components of the Department of Defense.

(a) General. (1) The Department acknowledges a particular responsibility for counseling and protecting members of the armed forces against drug abuse, for disciplining members who use or promote the use of drugs in an illegal or improper manner, and for attempting to restore and rehabilitate members using

drugs who evidence a desire and willingness to undergo such restoration.

(2) Appropriate disciplinary and administrative actions in cases of drug abuse will be dependent upon all the facts and circumstances of each case and will include consideration of whether the service member involved is a drug experimenter, drug user, drug addict, supplier, or casual supplier (as defined herein).

(1) Prior to initiating any administrative or disciplinary action against a person for using proscribed drugs, consideration will be given to the referral of such individual for medical evaluation.

(ii) In addition where restoration and rehabilitation efforts are deemed feasible, use will be made of such administrative and judicial tools as will insure that the service member is not prematurely and permanently precluded from participation in service sponsored or other government agency rehabilitation programs.

(b) Marijuana. Marijuana use is dangerous. It is a drug which has no known beneficial use. Its use, possession, transfer, or sale is prohibited by law. The maximum penalty prescribed for conviction by court-martial includes confinement at hard labor for 5 years and dishonorable discharge. Other laws of the United States, the individual States, and most countries in the world prohibit involvement with marijuana. The penalties vary and in some jurisdictions are much more severe than a court-martial may adjudge.

(1) There may be very definite and substantial detrimental effects on both the mental and physical well-being of the individual from the use of marijuana. Depending on the dose of the active ingredient, tetrahydrocannabinol (THC), found in marijuana, its use can induce psychotic reactions in almost any individual.

(2) Its use may also produce visual hallucinations, pronounced anxiety, and paranoid reactions lasting for hours. The muscular incoordination and the distortion of space and time perception commonly associated with marijuana use are potentially hazardous.

(3) The more prominent subjective effects include irritability, confusion, impairment of judgment and memory, and impairment of the verbal facility both in speaking and writing. The use of marijuana with other drugs may have a syner